Posted on Mar 20, 2020
President Trump Announces FDA Approval of Hydroxychloroquine for Treatment of Coronavirus
732
6
4
4
4
0
Posted in these groups: 
Office of the President (POTUS)
Office of the Vice President (VPOTUS)
Coronavirus COVID19
Health
Office of the President (POTUS) Office of the Vice President (VPOTUS) Coronavirus COVID19 Health
Posted >1 y ago
Responses: 3
2
2
0
0
0
0
Wonder if they will recall all the Vietnam combat medics who handed out the malaria and salt pills to us in the field and all but stared us down making sure we took them.
(0)
(0)
0
0
0
About that...
“ Two drugs, chloroquine and remdesivir, are being designated for Expanded Access, or “compassionate use,” by the FDA to address the novel coronavirus (COVID-19) pandemic, according to FDA Commissioner Stephen Hahn, MD, and President Donald Trump.1
Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications, but Expanded Access allows patients with serious or life-threatening cases of the virus to have access to them as investigational medicinal products”
https://www.pharmacytimes.com/news/fda-announces-two-drugs-approved-for-compassionate-use-in-treating-covid-19
Might work. Might not. Hence, “investigational use medicines.”
“ Two drugs, chloroquine and remdesivir, are being designated for Expanded Access, or “compassionate use,” by the FDA to address the novel coronavirus (COVID-19) pandemic, according to FDA Commissioner Stephen Hahn, MD, and President Donald Trump.1
Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications, but Expanded Access allows patients with serious or life-threatening cases of the virus to have access to them as investigational medicinal products”
https://www.pharmacytimes.com/news/fda-announces-two-drugs-approved-for-compassionate-use-in-treating-covid-19
Might work. Might not. Hence, “investigational use medicines.”
FDA Announces Two Drugs Given ‘Compassionate Use’ Status in Treating COVID-19
Chloroquine and remdesivir are not FDA-approved for a COVID-19 indications.
(0)
(0)
Read This Next
Continue with Facebook 
Continue with Google